NorthWest Biotherapeutics Inc (NWBO)

[Riley Hayes]

This sounds pretty positive to me.

"Having developed a strong basic/translational science foundation, Dr. Liau transitioned into the next stage of her career—a focus on patient care built upon a reverence for life, as she daily encountered GBM patients who had abandoned all hope. There are patients from her early immunotherapy vaccine trials who are now surpassing all odds, living up to 17 years after their deadly diagnosis was made, with phase III trials derived from her initial preclinical discoveries and phase I clinical results currently still ongoing. While she grew her clinical practice, her notoriety allowed her to grow an extended professional network within neurosurgery as well."